Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

This podcast was originally published by Cancer Care on June 20, 2019, here.

Listen Now

Topics Covered

  • Review of CLL
  • Significant Role of Testing in Informing Your Treatment Choices
  • First Line Treatment Options
  • Treatment of Relapsed/Refractory CLL
  • Importance of Re-Testing in Determining Treatment for 2nd and 3rd Line Treatments
  • Current Perspectives on New & Emerging Treatments for CLL
  • Key Questions to Ask & Re-Ask Your Health Care Team
  • Practical & Psychosocial Support to Cope with CLL
  • Questions for Our Panel of Experts

Our Panel of Experts

Alexey V. Danilov, MD, PhD

Associate Professor of Medicine, Knight Cancer Institute, Oregon Health & Science University (OHSU)

Lindsey E. Roeker, MD

Hematology/Medical Oncology Fellow, Department of Medicine, Memorial Sloan Kettering Cancer Center

Patricia Koffman

Co-Founder and Executive Director, CLL Society Inc.

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW

Director of Education and Training, CancerCare